reported that the proposed CT-based radiomics signature is associated with KRAS/NRAS/BRAF mutations; their study indicated that CT may be useful for the analysis of tumor genotype in colorectal cancer and thus helpful to determine therapeutic strategies (39). Here, KRAS is linked to colorectal cancer.